Cerebain Biotech Corp. Signs Agreement with Medical Device Product Development Company
The Company signs an agreement with Sonos Models, Inc. to assess the options for a medical device solution. Terms of the agreement to be finalized.
Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced today that it has signed an agreement with medical device product development company Sonos Models, Inc. (“Sonos”) to assess the Company’s options for a medical device solution.
Cerebain’s President, Gerald DeCiccio, stated, “We are excited about this partnership with Sonos to assess the Company’s options for a medical device. This agreement with Sonos is another step in the development process of Cerebain’s patent to discover products for the treatment of Alzheimer’s disease.”
About Discount Dental Materials, Inc.
Discount Dental Materials, Inc. was incorporated in Nevada on December 17, 2007. The Company’s business will revolve around the discovery of products for the treatment of Alzheimer’s disease utilizing Omentum. The Company’s approach will consider both a medical device solution as well as a synthetic drug solution. The Company’s operations will be conducted through its wholly-owned subsidiary, Cerebain Biotech Corp. For more information about Discount Dental and Cerebain Biotech, please visit the Company’s website at www.cerebain.com and www.otcmarkets.com, under the ticker symbol “DDOO,” to view the Company’s public filings and stock quote.
About Sonos Models, Inc.
Sonos Models, Inc. has provided industrial design services for 30 years to a wide spectrum of clientele including consumer products, toy, manufacturing, and medical industries. Sonos manages the entire development process from concept to production. The full range of services includes conceptual design, engineering, product prototypes, graphic design, e-commerce web design and short run or full production of a product. The latest 3D CAD solid modeling software, Stereolithography, rapid prototype and CNC technology (Computer Numerically Controlled) are utilized to ensure that product development and prototype samples are developed with optimum accuracy and efficiency.
Forward Looking Statements
This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's reports filed with OTC Markets. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved.
Discount Dental Materials, Inc.
Mr. Gerald DeCiccio, President